164 related articles for article (PubMed ID: 35778917)
1. Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.
Drobna-Śledzińska M; Maćkowska-Maślak N; Jaksik R; Kosmalska M; Szarzyńska B; Lejman M; Sędek Ł; Szczepański T; Taghon T; Van Vlierberghe P; Witt M; Dawidowska M
Genes Chromosomes Cancer; 2022 Dec; 61(12):720-733. PubMed ID: 35778917
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
Sharma ND; Nickl CK; Kang H; Ornatowski W; Brown R; Ness SA; Loh ML; Mullighan CG; Winter SS; Hunger SP; Cannon JL; Matlawska-Wasowska K
Cancer Sci; 2019 Jun; 110(6):1931-1946. PubMed ID: 30974024
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
4. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.
Lahera A; López-Nieva P; Alarcón H; Marín-Rubio JL; Cobos-Fernández MÁ; Fernández-Navarro P; Fernández AF; Vela-Martín L; Sastre I; Ruiz-García S; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
Br J Haematol; 2023 May; 201(4):718-724. PubMed ID: 36786170
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of microRNA-19b-3p-mediated SOCS3 in glioma through activation of JAK-STAT pathway.
Li T; Ge H; Yang Q; Wang J; Yin Q; Wang H; Hou G
Metab Brain Dis; 2023 Mar; 38(3):945-960. PubMed ID: 36484970
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
[TBL] [Abstract][Full Text] [Related]
7. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
Cells; 2020 May; 9(5):. PubMed ID: 32380791
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
[TBL] [Abstract][Full Text] [Related]
9. miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling.
Sha C; Jia G; Jingjing Z; Yapeng H; Zhi L; Guanghui X
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):177-187. PubMed ID: 32472154
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
11. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
12. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
[TBL] [Abstract][Full Text] [Related]
13. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling.
Ding D; Zhang Y; Zhang X; Shi K; Shang W; Ying J; Wang L; Chen Z; Hong H
Mol Biotechnol; 2022 Oct; 64(10):1143-1151. PubMed ID: 35438415
[TBL] [Abstract][Full Text] [Related]
14. miR-19b-3p integrates Jak-Stat signaling pathway through Plzf to regulate self-renewal in dairy goat male germline stem cells.
Clotaire DZJ; Du X; Wei Y; Yang D; Hua J
Int J Biochem Cell Biol; 2018 Dec; 105():104-114. PubMed ID: 30393202
[TBL] [Abstract][Full Text] [Related]
15.
Wang K; Gong D; Qiao X; Zheng J
Life Sci Alliance; 2023 Apr; 6(5):. PubMed ID: 37085288
[TBL] [Abstract][Full Text] [Related]
16. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series.
Hu M; Liu R; Li J; Zhang L; Cao J; Yue M; Zhong D; Tang R
Ann Hematol; 2023 Sep; 102(9):2445-2457. PubMed ID: 37209119
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of patients with mutations in the JAK/STAT signaling pathway in adult acute lymphoblastic leukemia].
Fan WJ; Xu TT; Guo JJ; Li YF; Jiang ZX
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):594-597. PubMed ID: 34455748
[No Abstract] [Full Text] [Related]
19. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
